Regeneron Pharmaceuticals (REGN) Other Accumulated Expenses (2010 - 2020)
Regeneron Pharmaceuticals (REGN) posted quarterly Other Accumulated Expenses of $122.4 million for Q4 2020, up 44.0% year-over-year from $85.0 million in Q1 2020, and up 26.32% quarter-over-quarter from $96.9 million in Q3 2020.
Regeneron Pharmaceuticals (REGN) Other Accumulated Expenses (2010 - 2020) Analysis & Trends
Regeneron Pharmaceuticals' Other Accumulated Expenses history runs 10 years deep, the most recent figure standing at $122.4 million for Q4 2020.
- In Q4 2020, Other Accumulated Expenses rose 44.0% year-over-year to $122.4 million; the TTM figure through Dec 2020 stood at $122.4 million (up 44.0% YoY), while the FY2020 annual figure was $122.4 million, up 44.0% from the prior year.
- Other Accumulated Expenses for Q4 2020 stood at $122.4 million, up from $96.9 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $122.4 million in Q4 2020, with the low at $267000.0 in Q4 2017.
- The 4-year median for Other Accumulated Expenses is $3.7 million (2016), against an average of $39.8 million.
- The sharpest annual moves came in 2016 and 2017: Other Accumulated Expenses jumped 518.22% in 2016, then plunged 93.51% in 2017.
- Regeneron Pharmaceuticals' Other Accumulated Expenses stood at $1.2 million in 2016, then slumped by 77.33% to $267000.0 in 2017, then jumped by 31735.21% to $85.0 million in 2019, then jumped by 44.0% to $122.4 million in 2020.
- Business Quant data shows REGN's Other Accumulated Expenses at $122.4 million in Q4 2020, $96.9 million in Q3 2020, and $103.8 million in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 122.40 Mn |
| Sep 30, 2020 | 96.90 Mn |
| Jun 30, 2020 | 103.80 Mn |
| Mar 31, 2020 | 85.00 Mn |
| Dec 31, 2019 | 85.00 Mn |
| Dec 31, 2017 | 267,000.00 |
| Sep 30, 2017 | 334,000.00 |
| Jun 30, 2017 | 397,000.00 |
| Mar 31, 2017 | 876,000.00 |
| Dec 31, 2016 | 1.18 Mn |
| Sep 30, 2016 | 3.59 Mn |
| Jun 30, 2016 | 3.70 Mn |
| Mar 31, 2016 | 13.51 Mn |
| Dec 31, 2015 | 13.56 Mn |
| Sep 30, 2015 | 2.51 Mn |
| Jun 30, 2015 | 2.29 Mn |
| Mar 31, 2015 | 2.19 Mn |
| Dec 31, 2014 | 97.15 Mn |
| Dec 31, 2013 | 939,000.00 |
| Jun 30, 2012 | 15.22 Mn |